In subgroup studies, there was a significant reduction in PON1 activity along with a decrease in HDL-C among the CAD(+)/DM(+) patients compared with the CAD(+)/DM(−) controls (Table 3). The gene discussed is PON1; the disease is coronary artery disorder.